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Mutations in human cardiac troponin I (cTnI) have been associated with restrictive,
dilated, and hypertrophic cardiomyopathies. The most commonly occurring residue on
cTnI associated with familial hypertrophic cardiomyopathy (FHC) is arginine (R), which is
also themost common residue at whichmultiplemutations occur. Two FHCmutations are
known to occur at cTnI arginine 204, R204C and R204H, and both are associated with
poor clinical prognosis. The R204H mutation has also been associated with restrictive
cardiomyopathy (RCM). To characterize the effects of different mutations at the same
residue (R204) on the physiological function of cTnI, six mutations at R204 (C, G, H, P, Q,
W) were investigated in skinned fiber studies. Skinned fiber studies showed that all tested
mutations at R204 caused significant increases in Ca2+ sensitivity of force development
(1pCa =50 0.22–0.35) when compared to wild-type (WT) cTnI. Investigation of the
interactions between the cTnI mutants and WT cardiac troponin C (cTnC) or WT cardiac
troponin T (cTnT) showed that all the mutations investigated, except R204G, affected
either or both cTnI:cTnT and cTnI:cTnC interactions. The R204H mutation affected
both cTnI:cTnT and cTnI:cTnC interactions while the R204C mutation affected only the
cTnI:cTnC interaction. These results suggest that different mutations at the same site on
cTnI could have varying effects on thin filament interactions. A mutation in fast skeletal
TnI (R174Q, homologous to cTnI R204Q) also significantly increased Ca2+ sensitivity of
force development (1pCa =50 0.16). Our studies indicate that known cTnI mutations
associated with poor prognosis (R204C and R204H) exhibit large increases in Ca2+
sensitivity of force development. Therefore, other R204 mutations that cause similar
increases in Ca2+ sensitivity are also likely to have poor prognoses.
Keywords: troponin I, familial hypertrophic cardiomyopathy, distal arthrogryposis, Ca2+ sensitivity, mammalian
two-hybrid
INTRODUCTION
Familial hypertrophic cardiomyopathy (FHC) is a genetically heterogeneous autosomal dominant
inherited heart disease of the myocardium that results in a high incidence of sudden
cardiac death and has been linked to mutations in genes coding for at least 10 sarcomeric
proteins. These mutations have been found in the genes for: α-myosin heavy chain
Abbreviations: FHC, familial hypertrophic cardiomyopathy; HcTnI, human cardiac troponin I; R204, arginine residue
204 on cardiac troponin I; TM, tropomyosin; Tn, troponin; TnC, troponin C; TnI, troponin I; TnT, troponin T; MOPS,
3-[N-morpholino]propanesulonic acid; WT, wild-type.
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(Geisterfer-Lowrance et al., 1990), cardiac myosin essential light
chain, and cardiac myosin regulatory light chain (Poetter et al.,
1996), α-tropomyosin (Thierfelder et al., 1994), cardiac troponin
T (TnT) (Thierfelder et al., 1994), cardiac myosin binding protein
C (Bonne et al., 1995; Watkins et al., 1995), cardiac troponin
I (TnI) (Kimura et al., 1997), α-actin (Mogensen et al., 1999),
troponin C (TnC) (Hoffmann et al., 2001), and titin (Satoh
et al., 1999). FHC is the most commonly identified cause of
sudden death in young adults. Symptoms of FHC vary between
individuals, and most patients are asymptomatic (or only exhibit
mild symptoms) before sudden cardiac death (O’Mahony and
Elliott, 2014).
TnI is a basic protein that readily interacts with the acidic TnC
and binds with another acidic protein, TnT, to form the Troponin
(Tn) complex (Zot and Potter, 1987; Tobacman, 1996; Westfall
and Metzger, 2001). TnI is also capable of binding actin and
inhibiting Mg2+-activated actomyosin ATPase and is commonly
referred to as the inhibitory subunit of Tn. The Tn complex and
tropomyosin are critical regulatory components of the muscle
contraction apparatus (Xu et al., 2010). Muscle contraction
involves cyclic binding and release of cross-bridges (myosin
heads of the thick filament interacting with and releasing actin
of the thin filament) with energy derived from the hydrolysis of
ATP.
Kimura et al. reported five missense mutations in TnI (R145G,
R145Q, R162W, G203S, and K206Q) that are linked to FHC
(Kimura et al., 1997). Since this initial report, several other
TnI FHC mutants [examples include R21C, P82S, K183 deletion
(1K183), I195M, D195N, S199N, R204C, R204H and an exon 8
deletion mutant encompassing the stop codon of the cTnI gene]
have also been reported (Kokado et al., 2000; Morner et al., 2000;
Niimura et al., 2002; Doolan et al., 2005). FHC mutations in TnI
and other myofilament proteins have been previously shown by
many groups to generally result in increased Ca2+-sensitivity of
force development (Gomes and Potter, 2004). Since R204 had
two known mutations (R204C and R204H), and arginine is the
amino acid most commonly associated with FHC in TnI or TnT
(Xu et al., 2010), it was hypothesized that any mutations at
R204 would cause similar increases in Ca2+-sensitivity of force
development. The R204 residue is an important amino acid to
investigate since families with the cardiac TnI (cTnI) R204H
mutation have a high incidence of sudden death (Doolan et al.,
2005). Doolan et al. (2005), investigated R162G, R162P, L198P,
R204H mutations and hypothesized that the FHC phenotype
of missense mutations of arginine residues of TnI are due to
disrupted functional interactions with TnC and TnT, which is
tested in the present work using multiple residue replacements
of R204.
The cTnI R204 residue is well conserved in different animals
suggesting that this residue is evolutionarily important. A
comparison of the primary amino acid sequence of cTnI and fast
skeletal Troponin I (fsTnI) shows that R204 residue corresponds
to the R174 residue of fsTnI. It is hypothesized that changes at the
fsTnI R174 residue will show similar increases in Ca2+-sensitivity
of force development as observed for the cTnI R204 mutants.
Since a known missense mutation (R174Q) in fsTnI was shown
to be associated with distal arthrogryposis type 2B (DA2B, also
known as arthrogryposis multiplex congenita, distal, type 2B)
(Westfall andMetzger, 2001), this mutation was also investigated
in skeletal muscle to determine if this mutation showed similar in
vitro physiological properties as the cTnI R204Qmutation. Distal
arthrogryposis (DA) refers to a group of disorders characterized
by multiple congenital contractures of the hands/wrists and
feet/ankles, and affected individuals typically have a triangular
shaped face, a small mouth, a prominent chin and positional foot
deformities (calcaneovalgus and/or clubfoot).
Investigation of six cTnI R204 residues as well as the fsTnI
R174Q mutation showed that all the mutations investigated
increased the Ca2+ sensitivity of force development. The different
effects of these mutants on the interaction between Tn subunits
and the maximal force suggest that the change in Ca2+ sensitivity
of force development may be a major determinant for the poor
prognosis of patients with the cTnI R204C, R204H, and fsTnI
R174Q mutations.
EXPERIMENTAL PROCEDURES
Mutation, Expression, and Purification of
HcTnI and HcTnI Mutants
The HcTnI FHCmutants were formed by overlapping PCR using
HcTnI cDNA obtained from Dr. J.D. Potter (Zhang et al., 1995).
Mutation, expression, and purification of cTnI and TnT mutants
were carried out as previously described (Szczesna et al., 2000;
Gomes et al., 2005b). The PCR products obtained were digested
with NcoI and BamH1 and then ligated to pET-3d vector. The
sequence of the TnI mutants was verified by sequencing prior
to expression and purification. HcTnI and HcTnI R204 mutants
were purified via conventional methods. Briefly, crude bacterial
supernatants were purified by column chromatography on an S-
Sepharose column at 4◦C and eluted with a linear KCl gradient
of 0–0.5 M in a Tris-HCl buffer containing 6M urea. Semi-
pure HcTnI and HcTnI mutantswere dialyzed against a solution
containing 50 mM Tris-HCl, pH 7.5, 1 M KCl, 1 M urea, 1 mM
DTT, and 2mMCaCl2 and loaded onto an affinity column having
covalently bound HcTnC. Pure HcTnI and HcTnImutants were
eluted with a gradient of 0–3 mM EDTA and 1–6 M urea. The
purity of the TnI proteins was determined by SDS-PAGE as
previously described (Gilda et al., 2016).
Mutation and Expression of Wild-Type and
Mutant Fast Skeletal TnI
The cDNA encoding rabbit fsTnI was previously cloned by
reverse transcriptase-polymerase chain reaction using a template
of total RNA from rabbit skeletal muscle and oligonucleotide
primers specific for the 5′ and 3′ regions of the respective coding
sequences (Sheng et al., 1992). Additionally, the fsTnI R174Q
mutant was made using a sequential overlapping polymerase
chain reaction-based method as previously described (Gomes
et al., 2004, 2005a). Clones were sequenced to verify the correct
sequences prior to expression and purification of the respective
proteins.
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Protein Purification of Rabbit Fast Skeletal
TnT, TnI, and TnC
The purification of fsTnI was similar to previously described (Pan
and Potter, 1992) with the exception that the final purification
step was with TnC-agarose affinity chromatography. Briefly, after
S-Sepharose cation exchange chromatography in the presence of
6M, fsTnI was eluted with a continuous ionic strength gradient
of 0 –0.3 M NaCl. The fsTnI containing fractions were pooled
and dialyzed in steps (to remove urea) with 6M urea, 4 M urea, 2
M urea in TnC affinity buffer to TnC affinity buffer with no urea
(50 mM Tris, pH 7.5 containing 2 mM CaCl2, 0.5M NaCl, and 1
mMDTT). A columnwith cardiac TnC immobilized onto CNBr-
activated Sepharose-4B (2mg TnC/ml agarose) was prepared as
described by Pharmacia LKB Biotechnology. The dialyzed TnI
was loaded onto the TnC-agarose column equilibrated with TnC
affinity buffer. The bound TnI was eluted with TnC elution buffer
containing 6 M urea and 3 mM EDTA (50 mM Tris, 0.5 mM
NaCl, 1 mM DTT, 3 mM EDTA, 6 M urea, pH 7.5). The eluates
were run on SDS gels and purified TnI pooled.
Formation of the Troponin Complex
Formation of the human cardiac troponin and rabbit skeletal
troponin complexes containing recombinant TnT, TnC, and TnI
was carried out as recently described by Szczesna et al. (2000),
(Szczesna et al., 2000; Gomes et al., 2005b). Proper stoichiometry
was verified by SDS-PAGE (Gilda et al., 2016). Although not done
routinely, gel filtration of these formed Tn complexes showed
that this reconstitution method resulted in a single species.
Preparation of Porcine Skinned Cardiac
Muscle Bundles
Cardiac skinned muscle fibers were prepared following a
common laboratory procedure published by Zhang et al. (1995)
(Zhang et al., 1995; Gomes et al., 2005a,b). Freshly isolated
porcine hearts were incubated in an O2-saturated solution
containing 140 mM NaCl, 4 mM KCl, 1.8 mM CaCl2, 1 mM
MgCl2, 1.8mMNaHPO4, 5.5mMglucose, and 5mMHEPES, pH
7.4. Cardiac muscle bundles were dissected from the left ventricle
of the porcine hearts and were chemically skinned by incubating
with 50% glycerol and 1% Triton X-100 in the relaxing solution
(pCa 8.0) containing 10−8 MCa2+, 5 mMMg2+, 7 mMEGTA, 20
mM MgATP, 20 mM creatine phosphate, and 15 U/mL creatine
phosphokinase, pH 7.0, at an ionic strength of 150 mM at 4
◦
C
for 24 h. These skinned muscle preparations were dissected into
small bundles (1–2 cm in length, 2–3 mm in diameter) and were
stored at –20
◦
C in the same solution without triton X-100 before
use.
Steady-State Force and Ca2+-Sensitivity of
Force Development of Tn Complexes
Containing HcTnI Mutants
The skinned fiber preparation was mounted with stainless
steel clips on a force transducer and was immersed in the
contracting solution to measure initial force before treatment.
The contraction solution (pCa 4) had the same composition as
the relaxation buffer except for the increased Ca2+ concentration
(10−4 M). To determine the Ca2+ dependence of force
development, the contraction of the skinned fibers was tested
in solutions of intermediate concentrations of Ca2+. The Ca2+
dependence of force was determined before and after performing
the displacement and reconstitution protocols that are described
below. To remove the endogenous Tn complex, the TnT
displacement method was used (Hatakenaka and Ohtsuki, 1992;
Szczesna et al., 2000; Gomes et al., 2005a). The cardiac fiber
was incubated with HCTnT (0.8 mg/mL) for a total of 2.5
h at room temperature with an intermediate buffer change
containing fresh HCTnT (0.8 mg/mL). After displacement of
the endogenous complex by HCTnT, the level of unregulated
force development was observed by measuring the level of
force reached by skinned fibers in both the pCa 8 solution
and the pCa 4 solutions. Restoration of the Ca2+ regulation
of force development was performed using troponin I:troponin
C complexes (30 µm) in pCa 8 solution for ∼1.5 h at room
temperature. To determine the Ca2+ dependence of force
development, the contraction of skinned fibers was tested in
solutions with intermediate concentrations of Ca2+ (from pCa
8 to pCa 4). The Ca2+ dependence was determined before
and after treatment of the skinned fibers with displacement
and reconstitution solutions. The Ca2+ dependence data were
analyzed using the Hill equation (Sigmaplot, Jandel Scientific):
relative force (%) = [Ca2+]n/([Ca2+]n+[pCa50]
n), where pCa50
is the pCa of a solution in which 50% of the change is produced,
and n is the Hill coefficient.
Steady-State Force and the
Ca2+-Sensitivity of Force Development of
Tn Complexes Containing Wild-Type and
FsTnIR174Q
Skeletal muscle fiber bundles from rabbit psoas muscle were
mounted on a force transducer and treated with the pCa 8
relaxing solution containing 1% Triton X-100 for ∼ 1 h. The
composition of the pCa 8 solution was 10−8 M [Ca2+], 1 mM
[Mg2+], 7 mM EGTA, 5 mM [MgATp2+], 20 mM imidazole,
pH 7.0, 20 mM creatinine phosphate, and 15 units/ml creatinine
phosphokinase, ionic strength = 150 mM. To determine the
Ca2+ sensitivity of force development, the fibers were gradually
exposed to the solutions of increasing Ca2+ concentrations, from
pCa 8 to pCa 4. To displace the endogenous Tn complex from
the fibers they were incubated in a solution containing 250 mM
KCI, 20 mM MOPS, pH 6.2, 5 mM MgCl2, 5 mM EGTA, 0.5
mM dithiothreitol, and 1.6–1.8 mg/ml fsTnT, for 1 h at room
temperature. A fresh fsTnT protein was applied to the fibers for
another 1 h incubation. This was to increase the efficiency of the
endogenous Tn displacement from the fibers. Displaced fibers
were then washed with the same solution without the protein
(10 min at room temperature) and tested for Ca2+-unregulated
force that developed due to the absence of the endogenous TnI
and TnC. The Ca2+ regulation of steady-state force was restored
with a preformed fsTnI·fsTnC complex. The reconstitution with
the fsTnI:fsTnC complex (25 µM) was performed in the pCa 8
solution for ∼1.5 h at room temperature, or long enough for the
force to reach a stable level. Control fibers were run in parallel
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and treated with the same solutions minus the proteins. The
final Ca2+-sensitivity of force development was determined after
fsTnI·fsTnC reconstitution and the data were analyzed with the
Hill equation.
Mammalian Two-Hybrid Studies
Protein:protein interactions were measured using the Checkmate
Mammalian Two-Hybrid System (Promega) as previously
described (Gilda et al., 2016). cTnI WT and cTnI deletion
mutants as well as WT cTnT, and cTnC were subcloned into
pACT and pBIND vectors. CV1 cells were transfected with
pACT and pBind DNA constructs as well as the pG5luc Vector.
TransIT-LT1 transfection reagent (Mirus) was used for all
experiments and cells were incubated for 36–48 h following
transfection with no media change. Cells were lysed and analyzed
using the dual luciferase reporter assay (Promega). To verify
the experiments were working correctly, control experiments
using various combinations of empty vectors, cTnI, cTnC, or
cTnT subcloned vectors were also carried out as previously
described (Gilda et al., 2016). To control for potential differential
protein expression in the two-hybrid assay, protein levels of the
wild-type, and TnI mutants (cloned into the mammalian two
hybrid plasmids) in CV1 cells were initially checked by Western
blotting to determine if any of the mutants investigated showed
significantly different expression levels. All TnI mutants were
found to show similar expression levels after 48 h.
Statistical Methods
All data are presented as mean ± S.D. Comparisons of
mammalian-two hybrid data and maximal force data were
carried out using one way ANOVA. Unpaired Student’s t-
test was used to determine the significance of differences in
1pCa (changes in half-maximal activating pCa in different
skinned fibers). Values of P < 0.05 were considered statistically
significant.
RESULTS
Figure 1A shows the primary structure of the C-terminal region
of cTnI with the cTnI FHC mutations that occur within
this region indicated. Figure 1B shows the primary sequence
alignment for HcTnI and human fsTnI (HfsTnI) indicating that
the position of the R204 mutation in HcTnI corresponds to R174
in HfsTnI.
Force Development and the Ca2+
Dependence of Force Development for
cTnI Mutations
To determine the effect of these mutations (R204C and R204H),
as well as other potential cTnI mutations, R204G, R204P, R204Q,
and R204W, cardiac skinned fiber calcium-force measurements
were carried out. We employed a well-established method in
our lab (Szczesna et al., 2000; Gomes et al., 2002; Lang et al.,
2002) to displace the endogenous Tn complex from skinned
porcine cardiac muscle preparations. After determining the level
of unregulated force in skinned fibers, they were incubated with
either wild-type or mutant HcTnI·HcTnC complexes in low
calcium buffer (pCa 8). This allowed us to determine whether
the TnI proteins could fully inhibit Ca2+ unregulated force
established after treatment with HcTnT and also to determine
if the proteins were able to fully reconstitute the skinned fibers
by forming a functional Tn complex. Wild-type HcTnI·HcTnC
complex resulted in complete inhibition of Ca2+ unregulated
force.
All six mutations showed significant increases in calcium
sensitivity of force development ranging from 1pCa50 0.22
(R204W) to 0.37 (R204G) (Figure 2, Table 1). The mutations
associated with FHC, R204C, and R204H, had 1pCa50 values
of 0.27 and 0.28 respectively (Figure 2, Table 1). Recovered
force is equivalent to the level of force developed in fibers after
reconstituting the fibers with the appropriate Tn complex. The
maximal force (force at pCa 4.0) obtained from the skinned fibers
was increased for cTnI R204W, R204C, and R204H mutations
relative to wild-type cTnI (Figure 3). It is interesting that both
known FHC mutations, R204C and R204H, increase maximal
force.
Mammalian Two-Hybrid
To determine the effect of the R204 mutations on cTnI: cTnT and
cTnI: cTnC interactions, the mammalian two-hybrid luciferase
assay was utilized. In the CheckMate
TM
mammalian two-hybrid
system utilized, the pACT vector contains the herpes simplex
virus VP16 activation domain upstream of the cloning region,
while the pBIND vector contains the yeast GAL4 DNA-binding
domain upstream of the cloning region. The pBIND Vector also
expresses Renilla reniformis luciferase under the control of the
SV40 promoter, which allows the normalization for differences in
transfection efficiency. The troponin subunits were cloned into
pBIND and pACT Vectors to generate fusion proteins with the
DNA-binding domain of GAL4 and the activation domain of
VP16, respectively. Association of the DNA-binding domain and
the transcriptional activation domain results in transcriptional
activation of the firefly luciferase reporter gene and an increase
in firefly luciferase expression when compared to the negative
controls. Mutations in interacting proteins that disrupt or
significantly reduce the interactions between the two proteins
being investigated would result in reduced association between
the DNA-binding domain and the transcriptional activation
domain resulting in less firefly luciferase expression.
The cTnI R204P and R204H mutations showed the weakest
interactions with cTnT when compared to wild-type cTnI
(Figure 4). The other mutations, including R204C, showed no
significant impairment when compared to wild-type cTnI. These
results suggest differences in the interactions between R204C
and R204H with cTnT. Four of the six mutations investigated
(R204Q, R204W, R204C, R204H) showed weaker interactions
with cTnC (Figure 5). The cTnI R204P mutation which showed
weaker interaction with cTnT, interacted with cTnC similarly
to wild-type cTnI (Figure 5). The cTnI R204G mutant also did
not show any significant impairment in cTnC binding when
compared to wild-type cTnI. The disruption in binding between
cTnI and its binding partners may be due to conformation
changes in cTnI caused by the mutations.
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FIGURE 1 | Primary structure of Human Cardiac Troponin I. (A) Alignment of the primary sequences of cardiac and fast skeletal Troponin I from different species.
Some of the cTnI FHC mutations that occur within this region are indicated. The location of the R204 mutation is indicated. M, mouse; RB, rabbit; H, human; R, rat; B,
bovine. (B) Alignment of the primary sequences of Human cardiac Troponin I (HCTNI) and Human fast skeletal Troponin I (HFSTNI). Human cardiac Troponin I
(Swiss-Prot accession number: P19429). Human fast skeletal Troponin I (Swiss-Prot accession number: P48788). *Indicates identical amino acid.: indicates homology.
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FIGURE 2 | Effect of mutations in Troponin I at R204 on the calcium sensitivity of force development. Each skinned muscle preparation was treated with
HcTnT to displace the endogenous Tn complex and subsequently reconstituted with either HcTnI·HcTnC, or HcTnI R204 mutant. (A) Comparison of HcTnI·HcTnC
and HcTnI R204Q·HCTnC. (B) Comparison of HcTnI·HcTnC and HcTnI R204C·HCTnC. (C) Comparison of HcTnI·HcTnC with HcTnI R204W·HcTnC or HcTnI
R204P·HcTnC. (D) Comparison of HcTnI·HcTnC with HcTnI R204H·HcTnC or HcTnI R 204G·HcTnC. The Ca2+ dependence of force was measured in each
preparation after reconstituting troponin. Each point is the average of 3 experiments and represents the mean ± S.D. *p < 0.05.
TABLE 1 | Effect of wild-type Human cTnI and mutants on the Ca2+ sensitivity of force development (pCa50) and the Hill coefficient (nH) in skinned
porcine cardiac muscle fibers.
Human cTnI Mutant pCa50 Difference from Wild-type (1pCa50) Hill coefficient (nH) Number of experiments (n)
Wild-type (204R) 5.66 ± 0.07 - 1.85 ± 0.23 3
204H 5.95 ± 0.08* 0.28 1.52 ± 0.08* 3
204G 6.04 ± 0.17* 0.37 1.51 ± 0.09* 3
204C 5.94 ± 0.07* 0.27 1.35 ± 0.07* 3
204W 5.89 ± 0.03* 0.22 1.50 ± 0.03* 3
204Q 5.98 ± 0.04* 0.31 1.46 ± 0.02* 3
204P 6.01 ± 0.01* 0.35 1.40 ± 0.06* 3
The pCa50 and nH values are the average of 3 independent fiber experiments, and the errors are the standard deviation (S.D.) values. * Indicates that the pCa50 values and Hill coefficient
for the respective TnI mutants are significantly different from wild-type HcTnI (p < 0.05).
Force Development and the Ca2+
Dependence of Force Development for
fsTnI
Rabbit fsTnI was studied in place of HfsTnI because it is the
best characterized fast skeletal muscle system and the C-terminal
half of rabbit fsTnI shows 100% homology with HfsTnI. The
homology between rabbit fsTnI and HfsTnI is 98.9%. Under the
conditions utilized, essentially all of the endogenous Tn complex
was displaced following treatment with fsTnT. The amount of
force development in the presence of very low concentration of
Ca2+ (pCa 8.0) after fsTnT displacement is a measure of the
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FIGURE 3 | Effect of mutations in Troponin I at R204 on Maximal force.
Each bar is the average of 3 experiments and represents the mean ± S.D.
Forces were normalized to the maximum force developed by each fiber after
TnT treatment and HcTnI·HcTnC reconstitution. *P < 0.05 (n = 3).
FIGURE 4 | Effect of mutations in Troponin I at R204 on its interaction
with Troponin T. Mammalian two-hybrid was utilized to determine disruptions
in the interactions between different cTnI’s and wild-type cTnT. *P < 0.05 (n =
4–5).
extent of displacement of endogenous fsTnI (referred to as the
Ca2+ unregulated force). In the absence of fsTnI, fibers were
unable to relax, as the inhibitory activity of cTnI is deficient. This
measurement of Ca2+ unregulated force was utilized to ensure
that all the skinned fibers are displaced to the same extent. All
the fibers selected for these studies had a Ca2+ unregulated force
of>95%.
After displacement and reconstitution, the maximal force
obtained for each fiber was measured. This force was measured
relative to the initial force of the skinned fibers before TnT
displacement. An R174Q fsTnI mutation (associated with DA)
increased the Ca2+ sensitivity of force development (Figure 6,
Table 2). The results suggest that mutations associated with
FIGURE 5 | Effect of mutations in Troponin I at R204 on its interaction
with Troponin C. Mammalian two-hybrid was utilized to determine
disruptions in the interactions between different cTnI’s and wild-type cTnC. *P
< 0.05 (n = 4–5).
FIGURE 6 | Effect of Wild-type Fast Skeletal TnI and TnI R174Q on
Ca2+-sensitivity of force development in skinned rabbit muscle fibers.
After TnT treatment the fibers were reconstituted with TnI·TnC complex.
Comparison of rabbit fibers after they were reconstituted with wild-type fsTnI
or fsTnI R174Q in the presence of fsTnC. The Ca2+ dependence of force was
measured in each preparation after reconstituting whole Tn. Each point is the
average of 3–5 experiments and represents the mean ±S.D.
significantly increased Ca2+ sensitivity of force development
may be associated with HCM in cardiac tissue or DA in
skeletal muscle. Unlike some of the cardiac R204 mutations
which showed increased maximal force, the fsTnI R174Qmutant
showed decreased maximal force relative to wild-type fsTnI
(Figure 7).
DISCUSSION
Arginine residues in cTnI are associated with multiple mutations
resulting in potentially different clinical phenotypes (Xu et al.,
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TABLE 2 | Effect of wild-type Rabbit Fast Skeletal TnI and TnI R174Q on the Ca2+-sensitivity of force development (pCa50) and the Hill coefficient (nH) in
skinned fast skeletal muscle fibers.
Fast skeletal TnI pCa50 Difference from Wild-type (1pCa50) Hill Coefficient (nH) Number of experiments (n)
Wild-type fsTnI 5.57 ± 0.01 - 1.64 ± 0.13 3
fsTnI R174Q 5.73 ± 0.03* 0.16 1.65 ± 0.10 5
*Indicates that the pCa50 values for the respective TnI mutants are significantly different from wild-type HcTnI (P < 0.05). The pCa50 and nH values are the average of 3-5 independent
fiber experiments, and the errors are the standard deviation (S.D.) values. The average wild-type TnI displacement was 97.6 ± 2.4%.
FIGURE 7 | Effect of Wild-type Fast Skeletal TnI and TnI R174Q on
force development in skinned muscle fibers. Maximal force development
of fibers after fsTnT displacement and fsTnI·fsTnC or fsTnI R174Q·fsTnC
reconstitution. Each bar is the average of 3–5 experiments and represents the
mean ± S.D. *P < 0.05.
2010). Since two mutations (R204C and R204H) at residue 204
of cTnI are associated with FHC and most mutations associated
with FHC show increased Ca2+-sensitivity of force development
(Xu et al., 2010), we hypothesized that any mutations at cTnI
R204 would cause significant increases in Ca2+-sensitivity of
force development. To characterize the effects that different
arginine mutations at the same residue would have on the
physiological function of cTnI, six mutations at R204 (C, G,
H, P, Q, W) were investigated in skinned fiber studies. All
of the cTnI R204 mutations investigated displayed increased
Ca2+ sensitivity of force development when compared to WT
cTnI (1pCa50 = 0.22–0.37), similar to what is observed for
most FHC mutations. These results suggest that the R204
residue is important in cTnI function and that increased Ca2+
sensitivity may be a major factor in HCM. The increase in
myofilament sensitivity to Ca2+ is important since reduction
in the Ca2+ sensitivity was found to prevent the development
of HCM (Alves et al., 2014). Others have suggested that
increased Ca2+-sensitivity is associated with HCM (Wei and Jin,
2015).
Certain regions of cTnI seem to be more important
functionally than other regions (Mogensen et al., 2015; Wei
and Jin, 2015; Meyer and Chase, 2016; Sheng and Jin, 2016).
It may be that any or most amino acid changes at certain
TnI residues that occur in regions functionally important
for regulating Ca2+-sensitivity would all be associated with
increased Ca2+-sensitivity of force development. Transgenic
mice expressing 9–17% of a C-terminal truncated human cardiac
TnI (residues 194–210 deleted, corresponding to residues 166–
182 of fsTnI), developed a phenotype of stunned myocardium
(Murphy et al., 2000). These results suggest that the 194–
210 region of cTnI is important for cTnI function. The FHC
mutations R204C and R204H both showed similar increases in
Ca2+ sensitivity (1pCa50 values of 0.28 and 0.29 respectively).
These two mutations also showed increased maximal force
compared to WT cTnI. R204W also showed increased maximal
force. The R204H mutation was found to be associated with
HCM in an Australian family and is associated with a poor
prognosis (Doolan et al., 2005).
To determine how R204 mutations might disrupt protein-
protein interactions, a mammalian two-hybrid luciferase assay
was used. Mutation of arginine to proline resulted in a significant
reduction in functional interactions with both cTnC and cTnT.
The results suggest that binding of cTnI mutants (except R204G)
to its binding partners is disrupted pending measurement of
actual affinity constants. Interestingly, while the R204C mutation
weakened the interaction of TnI with TnC, it did not significantly
affect the interaction of TnI with TnT. However, the cTnI
R204H mutation disrupted the interaction between cTnI and
cTnT as well as between cTnI and cTnC, which is consistent
with a previous report using a similar mammalian two hybrid
assay (Doolan et al., 2005). Doolan et al. found evidence for
altered interactions between TnI and either TnT, TnC, or both,
for cTnI R162G, R162P, L194P, and R204H mutations. The
previous finding that the cTnI R162G mutation reduced cTnI
and cTnT interaction while another mutation at the same cTnI
residue, R162P, did not affect cTnI-cTnT interaction (Doolan
et al., 2005) is consistent with our results which suggest that
not all cTnI HCM mutations affect cTnI-cTnT mutations. Using
the data obtained from the four mutations they investigated,
Doolan et al. concluded that altered interactions in the Tn
complex “increased severity of the disease.” The replacement
of cTnI arginine residue 204, a relatively large and charged
amino acid, by glycine, the smallest amino acid, resulted in
the largest increase in Ca2+-sensitivity of force development.
The severity of the disease is likely to be more complicated
due to altered interactions in the Tn complex since our R204G
results suggest increased Ca2+-sensitivity of force development
independent of any change in interactions with its Tn binding
partners.
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Replacement of arginine with proline also resulted in a large
increase in Ca2+ sensitivity of force development, which was
significantly larger than the increase in Ca2+ sensitivity of force
development observed for the R204W mutation (p < 0.05). This
difference in Ca2+ sensitivity changes may be due to the size
of the tryptophan residue, which is the largest amino acid and
closer to the size of arginine than proline or glycine (Morris
et al., 1992). Proline is also typically considered a structural
disruptor of the protein secondary structure and its side chains
are conformationally rigid, unlike glycine which can easily adopt
many main chain conformations.
To extend the hypothesis that any mutation at cTnI R204
would cause significant increases in Ca2+ sensitivity of force
development, we hypothesized that mutations at fsTnI R174,
which occurs at an equivalent location to the cTnI R204 residue,
would also cause significant increases in Ca2+-sensitivity of force
development. We investigated the R174Q missense mutation
associated with DA. TheWT rabbit fsTnI consists of 182 residues,
and the C-terminus region of fsTnI, which is affected by the
R174Q mutation, is known to interact with TnC and actin.
The fsTnI R174Q DA mutant showed increased Ca2+-sensitivity
of force development, similar to what was observed for the
cTnI R204Q mutation. Hence, the location of the R174Q DA
mutation is likely to be physiologically important for the function
of TnI. The R174Q was previously investigated by another
group that showed a greater increase in Ca2+-sensitivity of force
development (1pCa50 = 0.36) and no change in maximal force
(Robinson et al., 2007). The differences from what we observed
may be due to species of cTnI utilized, as Robinson et al. utilized
human fsTnI in muscle fibers in rabbit skeletal muscle fibers
while we utilized rabbit fsTnI in rabbit skeletal muscle fibers
(Robinson et al., 2007). However, in both cases the increase in
Ca2+-sensitivity of force development relative to WT fsTnI was
significant.
DA occurs in about 1 in 3000 children, and other fsTnI
mutations have been found to be associated with DA2B
(fsTnI R156ter, K175del, and K176del mutations) (Kimber
et al., 2012). Patients with DA2B have contractures which
are present at birth, suggesting impaired relaxation of muscle
fibers. A likely possibility is that the higher Ca2+-sensitivity of
force development in fibers containing DA2B mutations affects
muscle contracture. These results, as well as two other reports
that showed increased Ca2+-sensitivity with DA2B mutations
(Robinson et al., 2007; Mokbel et al., 2013), all suggest that
joint and muscle contractures may be caused by prolonged
muscle hypercontraction due to increased myofibrillar calcium
sensitivity and that treatments that reduce skeletal muscle Ca2+
sensitivity may be beneficial to patients with DA2B.
Overall, these results suggest that different amino acids at
the same site on cTnI could affect thin filament interactions
differentially. While significant impairment in the interactions
of cTnI with TnT or TnC may be enough to cause significant
changes in Ca2+-sensitivity of force development, impairment
in these interactions is not a requirement for altering the Ca2+-
sensitivity as our study showed that R204G had the largest
increase in Ca2+-sensitivity yet demonstrated maximal tension
and cTnI:TnT/TnC interactions comparable to wild-type levels.
While R204G did not show any altered interactions between
cTnI and TnC or TnT it is possible that altered interactions
between TnI R204G and actin may occur. Unfortunately, we
were unable to get cTnI:actin two hybrid studies to work well.
It may also be possible that the R204 mutations are affecting
thin and thick filament interactions by disturbing tropomyosin
displacement. If the large increase in Ca2+-sensitivity of force
development observed with these mutations is associated with
the poor prognosis, then many other R204 mutations that
may be discovered in the population are likely to have poor
prognoses.
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